author-photo

Philippe Rey

38

Papers

249

Citations

Citation Trend

Filter By

Papers (27) Sort By

Journal Conference Others

Place d’une coordination de parcours complexes en cancérologie par des infirmiers libéraux coordinateurs

2021 Bulletin Du Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Improved survival in multiple myeloma during the 2005-2009 and 2010-2014 periods.

2021 Leukemia
Show All
- Source
- Cite
- Save
Citations (2)
Therapy-Related Acute Myeloid Leukemia (t-AML) and the Advantage of Intensive Chemotherapy: Real-Life Analysis from Two Regional French Centers

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Retrospective Evaluation of Rituximab, Methotrexate, Procabazine, Vincristine and Etoposide Followed By Consolidation with Rituximab, Aracytine and Ifosfamide for Elderly Patients with Newly Diagnosed Primary CNS Lymphoma

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Study of Treatment Complications in Oncology / Hematology Patients: Protocol for a Prospective and Interventional Cohort Study from the Pasca Program

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Apixaban for the prevention of thromboembolism in immunomodulatory‐treated myeloma patients: Myelaxat, a phase 2 pilot study

2019 American Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (24)
Arbres décisionnels de l'article : Gros foie douloureux

2019
Show All
- Source
- Cite
- Save
Citations (0)
AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION FOR LYMPHOID MALIGNANCIES IN PATIENTS OF 65 YEARS OLD AND BEYOND: A SINGLE CENTER FEASIBILITY EXPERIENCE

2019 Journal of Geriatric Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Personalised Follow-up Program after Acute Phase of Treatment in Oncology/Hematology Patients Towards Early Intervention, Better Care and Quality of Life Improvement: Results from Pasca Pilot Study

2019 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Ritumixab in Combination with Adapted-Dose of Ifosfamide and Etoposide As Salvage Treatment in Elderly Refractory/Relapsed Diffuse Large B-Cell Lymphoma Patients Non-Candidate for High Dose Therapy: A Retrospective Study of Lyon Hospital University

2018 Blood
Show All
- Source
- Cite
- Save
Citations (0)